Olivier Chabre
Overview
Explore the profile of Olivier Chabre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2795
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cristante J, Chabre O
Ann Endocrinol (Paris)
. 2023 Mar;
84(3):370-372.
PMID: 36963757
Prolonged exposition to supraphysiological doses of exogenous glucocorticoid eventually results in iatrogenic Cushing's syndrome, whose intensity depends on the dose and duration of the treatment and on individual susceptibility. In...
12.
Dormoy A, Haissaguerre M, Vitellius G, Do Cao C, Geslot A, Drui D, et al.
J Clin Endocrinol Metab
. 2022 Dec;
108(6):1475-1487.
PMID: 36470583
Context: Prospective studies have demonstrated the efficacy of osilodrostat in Cushing disease. No study has evaluated osilodrostat in a series of patients with paraneoplastic Cushing syndrome/ectopic adrenocorticotropin syndrome (PNCS/EAS). Objective:...
13.
Valassi E, Castinetti F, Ferriere A, Tsagarakis S, Feelders R, Netea-Maier R, et al.
Endocr Relat Cancer
. 2022 Oct;
29(12):681-691.
PMID: 36197784
Corticotroph tumor progression after bilateral adrenalectomy/Nelson's syndrome (CTP-BADX/NS) is a severe complication of bilateral adrenalectomy (BADX). The aim of our study was to investigate the prevalence, presentation and outcome of...
14.
Magnier O, Chabre O, Schiff I, Sartelet H, Combaret V, Roux J, et al.
J Adolesc Young Adult Oncol
. 2022 Sep;
12(4):604-610.
PMID: 36169643
Pheochromocytoma/neuroblastoma composite tumors are rare entities for which little is known. We report an atypical case of a 39-year-old man with secondary bone locations of a composite tumor, 7 years...
15.
Chabre O, Muller M, Cristante J, Cracowski J, Gay E
Lancet Diabetes Endocrinol
. 2022 May;
10(6):384-385.
PMID: 35597254
No abstract available.
16.
Potorac I, Bonneville J, Daly A, de Herder W, Fainstein-Day P, Chanson P, et al.
J Clin Endocrinol Metab
. 2022 May;
107(8):e3313-e3320.
PMID: 35512251
Context: Ectopic acromegaly is a consequence of rare neuroendocrine tumors (NETs) that secrete GHRH. This abnormal GHRH secretion drives GH and IGF-1 excess, with a clinical presentation similar to classical...
17.
Tabarin A, Assie G, Barat P, Bonnet F, Bonneville J, Borson-Chazot F, et al.
Ann Endocrinol (Paris)
. 2022 Feb;
83(2):119-141.
PMID: 35192845
Cushing's syndrome is defined by prolonged exposure to glucocorticoids, leading to excess morbidity and mortality. Diagnosis of this rare pathology is difficult due to the low specificity of the clinical...
18.
Bargas S, Mc Leer A, Mondet J, Chabre O, Laramas M
Eur J Endocrinol
. 2022 Feb;
186(4):K5-K8.
PMID: 35118995
rearrangements represent a very rare genomic abnormality among all cancers but can be detected in thyroid cancer with a non-negligible frequency of 2%. Dramatic clinical responses to therapies targeting NTRK...
19.
Felix L, Jacon P, Lugosi M, Cristante J, Roux J, Chabre O
Eur Thyroid J
. 2022 Jan;
11(1).
PMID: 34981744
Background And Objective: It has been reported recently in a cross sectional study that patients with amiodarone induced thyrotoxicosis (AIT) showed a 'white' thyroid on unenhanced computed tomography, due to...
20.
Tabarin A, Haissaguerre M, Lassole H, Jannin A, Paepegaey A, Chabre O, et al.
Eur J Endocrinol
. 2021 Dec;
186(2):K1-K4.
PMID: 34905500
No abstract available.